Why the study?
Can machine learning successfully stratify Japanese HFpEF patients into distinct phenogroups?
Can machine learning successfully stratify Japanese HFpEF patients into distinct phenogroups?
Answers are grounded in this paper and cite their sources.
Machine learning can successfully identify distinct clinical phenogroups in Japanese patients with HFpEF, which may aid in personalized management.
ML could successfully stratify Japanese HFpEF patients into three phenogroups (atherosclerosis and chronic kidney disease, atrial fibrillation, and younger and left ventricular hypertrophy groups).
No takes yet. Share an insight, caveat, or question.
Kyodo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: